Quantum Genomics SA (ALQGC) - Cash Flow Conversion Efficiency

Latest as of June 2023: -4.706x

Based on the latest financial reports, Quantum Genomics SA (ALQGC) has a cash flow conversion efficiency ratio of -4.706x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-7.64 Million ≈ $-8.93 Million USD) by net assets (€1.62 Million ≈ $1.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ALQGC equity to assets ratio to measure how much of total assets are equity-financed.

Quantum Genomics SA - Cash Flow Conversion Efficiency Trend (2012–2022)

This chart illustrates how Quantum Genomics SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore ALQGC long-term investment intensity to see how much of total assets are deployed in long-term investments.

Quantum Genomics SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Quantum Genomics SA ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Multi-Usage Holdings Bhd KLSE:9539	-0.035x
Ace Digital AS OL:ACED	N/A
Catella AB A ST:CAT-A	-0.043x
Dhruv Consultancy Services Limited NSE:DHRUV	0.035x
SIV Capital Ltd AU:SIV	0.020x
Altur Slatina RO:ALT	N/A
INDUSTRIAL MINERALS LTD F:9ED	N/A
Nandani Creation Limited NSE:JAIPURKURT	-0.166x

Annual Cash Flow Conversion Efficiency for Quantum Genomics SA (2012–2022)

The table below shows the annual cash flow conversion efficiency of Quantum Genomics SA from 2012 to 2022. For the full company profile with market capitalisation and key ratios, see market value of Quantum Genomics SA.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2022-12-31	€3.61 Million ≈ $4.22 Million	€-20.21 Million ≈ $-23.63 Million	-5.603x	-218.28%
2021-12-31	€9.67 Million ≈ $11.30 Million	€-17.02 Million ≈ $-19.89 Million	-1.760x	-261.87%
2020-12-31	€24.65 Million ≈ $28.82 Million	€-11.99 Million ≈ $-14.02 Million	-0.486x	+56.12%
2019-12-31	€9.41 Million ≈ $11.00 Million	€-10.43 Million ≈ $-12.19 Million	-1.109x	-20.70%
2018-12-31	€11.87 Million ≈ $13.87 Million	€-10.90 Million ≈ $-12.74 Million	-0.919x	-2.15%
2017-12-31	€8.87 Million ≈ $10.37 Million	€-7.98 Million ≈ $-9.33 Million	-0.899x	-91.70%
2016-12-31	€11.79 Million ≈ $13.79 Million	€-5.53 Million ≈ $-6.47 Million	-0.469x	-19.75%
2015-12-31	€8.02 Million ≈ $9.38 Million	€-3.14 Million ≈ $-3.67 Million	-0.392x	-101.82%
2014-12-31	€-129.79K ≈ $-151.74K	€-2.79 Million ≈ $-3.26 Million	21.503x	+3447.81%
2013-12-31	€-1.63 Million ≈ $-1.90 Million	€-987.00K ≈ $-1.15 Million	0.606x	-9.37%
2012-12-31	€-918.08K ≈ $-1.07 Million	€-614.00K ≈ $-717.83K	0.669x	--

About Quantum Genomics SA

PA:ALQGC France Biotechnology

Market Cap

$5.87 Million

€5.02 Million EUR

Market Cap Rank

#28538 Global

#514 in France

Share Price

€0.07

Change (1 day)

+0.00%

52-Week Range

€0.07 - €0.07

All Time High

€9.73